Delivery Order SPE2DB22D2211-SPE2DB24FMVF5
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,643.99 firm fixed-price delivery order contract is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The contract has an ultimate completion date of May 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,902.39 Firm Fixed Price Delivery Order is for the supply of 4 mg Ondansetron ODT (Orally Disintegrating Tablet) in 30-count packages. The contract has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,626.35, is for the delivery of Ondansetron ODT 4 mg tablets in quantities of 30 per package. The contract is a Firm Fixed Price Delivery Order with a completion date of March 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,805.20 firm fixed-price delivery order is for the supply of 4 mg ondansetron orally disintegrating tablets. The contract has a completion date of November 14, 2024 and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,703.54 firm fixed-price delivery order is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in quantities of 30. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen to provide a comprehensive range of pharmaceutical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,605.34 firm-fixed-price delivery order is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which covers a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,919.77 firm fixed-price delivery order contract is for the supply of 4 mg ondansetron orally disintegrating tablets. The contract has an ultimate completion date of December 14, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,056.68 Firm Fixed Price Delivery Order is for the supply of 4566817390 - Ondansetron ODT 4 mg Tablets, 30s, with a performance period through January 2, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,790.90 firm fixed-price delivery order is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets to support federal healthcare programs. The contract is not designated with a set-aside requirement, indicating open competition. It is associated with a larger Indefinite Delivery Contract (IDC) held by...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,147.40 firm fixed-price contract is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The ultimate completion date is February 7, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB24FMVF5Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,067.40 firm fixed-price delivery order is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets (ODT) in 30-count packages. The contract has a period of performance through February 16, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 2/15/24 |